| # | Drug | Count |
|---|---|---|
| 0 | ZIDOVUDINE | 4 |
| 1 | LAMIVUDINE | 3 |
| 2 | CABOZANTINIB | 2 |
| 3 | ETANERCEPT | 2 |
| 4 | PAZOPANIB HYDROCHLORIDE | 2 |
| 5 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 1 |
| 6 | ACITRETIN | 1 |
| 7 | ALBUTEROL SULFATE | 1 |
| 8 | AMLODIPINE | 1 |
| 9 | AVAPRITINIB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZIDOVUDINE | 4 | 0.0004 |
| 1 | ACITRETIN | 1 | 0.0002 |
| 2 | FLUOCINONIDE TOPICAL SOLUTION USP, 0.05% | 1 | 0.0002 |
| 3 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 1 | 0.0002 |
| 4 | LAMIVUDINE | 3 | 0.0001 |
| 5 | REGORAFENIB | 1 | 0.0001 |
| 6 | PAZOPANIB HYDROCHLORIDE | 2 | 0.0001 |
| 7 | CABOZANTINIB | 2 | 0.0000 |
| 8 | VALPROIC ACID | 1 | 0.0000 |
| 9 | IPILIMUMAB | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0001 |
| 1 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0000 |
| 2 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 5 | Purine Antimetabolite [EPC] | 1 | 0.0000 |
| 6 | Aromatase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Calcineurin Inhibitor Immunosuppressant [EPC] | 1 | 0.0000 |
| 8 | Mood Stabilizer [EPC] | 1 | 0.0000 |
| 9 | Anti-epileptic Agent [EPC] | 1 | 0.0000 |